Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells. [electronic resource]
Producer: 20181113Description: 44075 p. digitalISSN:- 2045-2322
- Anoikis
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- complications
- Cell Adhesion
- Cell Cycle Checkpoints
- Cell Line, Tumor
- Cell Proliferation
- Gefitinib
- Glioblastoma -- complications
- Humans
- Neovascularization, Pathologic -- complications
- Phenylurea Compounds -- therapeutic use
- Quinazolines -- therapeutic use
- Quinolines -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.